Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1970 3
1971 4
1972 1
1973 2
1974 2
1976 1
1977 4
1978 5
1979 1
1980 2
1981 2
1982 1
1983 7
1984 4
1985 3
1986 5
1987 5
1988 6
1989 2
1990 8
1991 8
1992 7
1993 16
1994 12
1995 12
1996 14
1997 19
1998 15
1999 27
2000 36
2001 28
2002 46
2003 39
2004 62
2005 71
2006 89
2007 101
2008 108
2009 137
2010 153
2011 233
2012 241
2013 221
2014 244
2015 320
2016 257
2017 262
2018 283
2019 252
2020 266
2021 279
2022 269
2023 290
2024 266
2025 232
2026 128

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,520 results

Results by year

Filters applied: . Clear all
Page 1
Trigeminal neuralgia.
Ashina S, Robertson CE, Srikiatkhachorn A, Di Stefano G, Donnet A, Hodaie M, Obermann M, Romero-Reyes M, Park YS, Cruccu G, Bendtsen L. Ashina S, et al. Among authors: park ys. Nat Rev Dis Primers. 2024 May 30;10(1):39. doi: 10.1038/s41572-024-00523-z. Nat Rev Dis Primers. 2024. PMID: 38816415 Review.
Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial.
Matino D, Palladino A, Taylor CT, Hwang E, Raje S, Nayak S, McDonald R, Acharya SS, Mahlangu J, Jiménez-Yuste V, Choraria N, Yang R, Li CK, Al-Khabori M, Wali Y, Morales Adrián J, Park YS, Zülfikar OB, Teeter J. Matino D, et al. Among authors: park ys. Blood. 2025 Oct 2;146(14):1654-1663. doi: 10.1182/blood.2024027468. Blood. 2025. PMID: 40608864 Free PMC article. Clinical Trial.
A2 milk consumption and its health benefits: an update.
Jeong H, Park YS, Yoon SS. Jeong H, et al. Among authors: park ys. Food Sci Biotechnol. 2023 Oct 25;33(3):491-503. doi: 10.1007/s10068-023-01428-5. eCollection 2024 Feb. Food Sci Biotechnol. 2023. PMID: 38274187 Free PMC article. Review.
Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial.
Matino D, Acharya SS, Taylor CT, Sun P, Agathon D, Raje S, Gould T, Palladino A, Mahlangu J, Lissitchkov T, Todorova M, Chan A, Carcao M, Sun J, Yang R, Wu R, Jin C, Zeng X, Boban A, Bilic E, Frenzel L, Fung Chan GC, Kong Li C, Apte S, Choraria N, Chistolini A, Marchesini E, Peyvandi F, Fujii T, Matsushita T, Kaneda M, Lyu CJ, Park YS, Kim S, Martinez LV, Adrian JM, Wali Y, Al Khabori M, Kurtov I, Alzahrani H, Zaher G, Micic D, Miljic P, Kostic G, Vucic M, Djurdjevic P, Hidalgo OB, Porras JG, Jiménez-Yuste V, Calvo Villas JM, Lopez Fernandez MF, Albayrak C, Okan V, Balkan C, Sahin F, Antmen A, Unal E, Visweshwar N, Sharathkumar A, Kruse-Jarres R. Matino D, et al. Among authors: park ys. Blood. 2026 Feb 26;147(9):920-931. doi: 10.1182/blood.2025031065. Blood. 2026. PMID: 41351884 Free PMC article. Clinical Trial.
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial.
Hecht JR, Park YS, Tabernero J, Lee MA, Lee S, Virgili AC, Van den Eynde M, Fontana E, Fakih M, Asghari G, So J, Stein A, Dubreuil O, Bodnar L, He CS, Wang G, Smith R, Eng C, Saeed A; STELLAR-303 study investigators. Hecht JR, et al. Among authors: park ys. Lancet. 2025 Nov 15;406(10517):2360-2370. doi: 10.1016/S0140-6736(25)02025-2. Epub 2025 Oct 20. Lancet. 2025. PMID: 41130252 Clinical Trial.
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.
Kang YK, Kim HD, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Cheong JH, Jeong O, Heo MH, Kim HK, Park C, Yoo CH, Kang SY, Zang DY, Jang YJ, Sul JY, Kim JG, Kim BS, Beom SH, Hwang JE, Ryu SW, Kook MC, Ryoo BY, Kim H, Yoo MW, Lee NS, Lee SH, Noh SH. Kang YK, et al. Among authors: park ys. J Clin Oncol. 2024 Sep 1;42(25):2961-2965. doi: 10.1200/JCO.23.02167. Epub 2024 Jul 12. J Clin Oncol. 2024. PMID: 38996201 Clinical Trial.
Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies.
Klamroth R, von Drygalski A, Hermans C, Park YS, Chan AKC, Kupesiz A, Alvarez-Román MT, Malec L, Santagostino E, Neill G, Bystrická L, Dumont J, Abad-Franch L, Fetita LS, Khoo L. Klamroth R, et al. Among authors: park ys. Haemophilia. 2025 May;31(3):391-400. doi: 10.1111/hae.70017. Epub 2025 Mar 18. Haemophilia. 2025. PMID: 40099428 Free PMC article. Clinical Trial.
4,520 results